Latest news and press releases about HeartBeam, Inc. (BEAT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Price
| Price | $0.41 |
| Market Cap | $23M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.64 |
| EV / EBITDA | -0.74 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -686.78% |
| Return on Invested Capital | -249.58% |
| Return on Assets | -190.81% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: CRVO · EQ · HOWL · INKT · IOBT · MDAI · ONMD
Explore sector: Healthcare · Medical - Specialties
More sections of BEAT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks